Scleroderma in children

Pediatr Clin North Am. 2005 Apr;52(2):521-45, vii. doi: 10.1016/j.pcl.2005.02.001.

Abstract

This article discusses the various clinical, laboratory, and therapeutic aspects of systemic sclerosis and localized scleroderma in children. The close collaboration among pediatricians, rheumatologists, and dermatologists represents an important advance in the management of these disabling conditions.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use
  • Child
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Scleroderma, Systemic / diagnosis*
  • Scleroderma, Systemic / drug therapy
  • Scleroderma, Systemic / physiopathology

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents